scispace - formally typeset
F

Farzad Kobarfard

Researcher at Shahid Beheshti University of Medical Sciences and Health Services

Publications -  279
Citations -  5141

Farzad Kobarfard is an academic researcher from Shahid Beheshti University of Medical Sciences and Health Services. The author has contributed to research in topics: Chemistry & Detection limit. The author has an hindex of 29, co-authored 260 publications receiving 3669 citations. Previous affiliations of Farzad Kobarfard include Shahid Beheshti University & University of Tehran.

Papers
More filters
Journal ArticleDOI

Optimization of Growth Conditions of Lentinus edodes Mycelium and Polysaccharides on Walnut Shell by-Products Using Response Surface Analysis

TL;DR: The objective of this study was to optimize mycelium and polysaccharide production by L. edodes on walnut shell through a two-step procedure including a one-factor-at-a-time approach to select the most important factors and a response surface methodology design to determine their optimum combinations.
Journal ArticleDOI

Isolation of membrane-active fraction of Streptomyces spp. from soil

TL;DR: Streptomyces-produced 08346 strain demonstrates good antimicrobial activities against bacteria and yeasts, suggesting its potential as an antimicrobial membrane-active agent.
Journal ArticleDOI

Biological Evaluation of the Isolated Compounds from Methanol fraction of Leutea avicennia Mozaff.

TL;DR: Investigation of the antioxidant activity and acetylcholinestrase inhibition of the crude extract, fractions, and isolated compounds from methanol fraction of L. avicenniae revealed bioactive components with antioxidant and AChE inhibitory effects.
Journal ArticleDOI

The Impact of Clopidogrel Resistance on Clinical Outcome of Iranian Patients Undergoing Percutaneous Coronary Intervention.

TL;DR: This study showed 24.76% resistance to clopidogrel in Iranian population but, it did not find any correlation between clopIDogrel resistance and cardiac events in follow up maybe due to study limitations particularly missed follow-up in non-responder patients.